Previous Article | Next Article 
J Virol, May 1998, p. 3837-3844, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Temporal Mapping of Transcripts in Herpesvirus
6 Variants
Prisco
Mirandola,
Paola
Menegazzi,
Stefania
Merighi,
Tullia
Ravaioli,
Enzo
Cassai, and
Dario
Di Luca*
Dipartimento di Medicina Sperimentale e
Diagnostica, Sezione di Microbiologia, Università di Ferrara,
Ferrara, Italy
Received 22 December 1997/Accepted 30 January 1998
To define the molecular features characteristic of the early stages
of infection of lymphocytes with human herpesvirus 6 (HHV-6) variant A
or B, we studied the temporal regulation of expression of selected sets
of viral genes. Thus, U42, U94, U89-U90, U73, and U39 are
genes
since their transcripts (i) were made in the presence of inhibitors of
protein synthesis and (ii) were detected 3 h after infection of
untreated cells. U41, U53, U31, and U19 are
genes since their
expression is inhibited by cycloheximide but not by phosphonoacetate,
an inhibitor of DNA synthesis. U100 is a
gene since its spliced
transcript encoding the structural glycoprotein gp82/105 was first
detected 16 h after infection of untreated cells but could not be
detected in cells treated with phosphonoacetate. HHV-6 variants differ
in the transcription patterns of their genes. U16-U17 originates a
splice transcript and is regulated as
in HHV-6B and as
in
HHV-6A. U91 generates two transcripts, amplified as 476- and 374-bp PCR
fragments. The 476-bp fragment is
in HHV-6A-infected cells but
in HHV-6B-infected cells. Conversely, the 374-bp fragment is
in
HHV-6A-infected cells and
in HHV-6B-infected cells. Furthermore,
the spliced product of U18-U19-U20 (526 bp) is
in HHV-6A-infected
cells, but only a partially spliced form (1.9 kb) was detected at late stages of infection in HHV-6B. HHV-6 transcription was also studied in
nonproductive lymphoid cells, and the same transcription pattern detected during lytic infection was observed. Also, HHV-6 variants maintain the differences in U91, U16-17, and U18-U19-U20. We conclude that, as expected from the sequencing data, gene expression is generally similar in HHV-6 variants. However, transcription of selected
genes in HHV-6A and HHV-6B differs with respect to temporal regulation
and splicing pattern. Furthermore, the identification of viral
functions expressed during the different stages of lytic replication
suggests that reverse transcription-PCR for HHV-6 genes is a useful
diagnostic approach to differentiate between latent and productive
HHV-6 infection.
*
Corresponding author. Mailing address: Sezione di
Microbiologia, Dipartimento di Medicina Sperimentale e Diagnostica,
Università di Ferrara, Via Borsari 46, 44100 Ferrara, Italy.
Phone: (39) 532 291408. Fax: (39) 532 247618. E-mail:
dil{at}dns.unife.it.
J Virol, May 1998, p. 3837-3844, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tsao, E. H., Kellam, P., Sin, C. S. Y., Rasaiyaah, J., Griffiths, P. D., Clark, D. A.
(2009). Microarray-based determination of the lytic cascade of human herpesvirus 6B. J. Gen. Virol.
90: 2581-2591
[Abstract]
[Full Text]
-
Comar, M, D'Agaro, P, Campello, C, Poli, A, Breinholt, J P III, Towbin, J A, Vatta, M
(2009). Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J. Clin. Pathol.
62: 80-83
[Abstract]
[Full Text]
-
Kofod-Olsen, E., Ross-Hansen, K., Mikkelsen, J. G., Hollsberg, P.
(2008). Human herpesvirus 6B U19 protein is a PML-regulated transcriptional activator that localizes to nuclear foci in a PML-independent manner. J. Gen. Virol.
89: 106-116
[Abstract]
[Full Text]
-
Alvarez-Lafuente, R., de las Heras, V., Garcia-Montojo, M., Bartolome, M., Arroyo, R.
(2007). Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult Scler
13: 578-583
[Abstract]
-
Comar, M., D'Agaro, P., Horejsh, D., Galvan, M., Fiorentini, S., Andolina, M., Caruso, A., Di Luca, D., Campello, C.
(2005). Long-Lasting CD3+ T-Cell Deficiency after Cord Blood Stem Cell Transplantation in a Human Herpesvirus 6-Infected Child. J. Clin. Microbiol.
43: 2002-2003
[Abstract]
[Full Text]
-
De Bolle, L., Naesens, L., De Clercq, E.
(2005). Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy. Clin. Microbiol. Rev.
18: 217-245
[Abstract]
[Full Text]
-
Alvarez-Lafuente, R., De las Heras, V., Bartolome, M., Picazo, J. J., Arroyo, R.
(2004). Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection. Arch Neurol
61: 1523-1527
[Abstract]
[Full Text]
-
Rotola, A, Merlotti, I, Caniatti, L, Caselli, E, Granieri, E, Tola, M R, Di Luca, D, Cassai, E
(2004). Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler
10: 348-354
[Abstract]
-
Dockrell, D.H.
(2003). Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol
52: 5-18
[Abstract]
[Full Text]
-
Stanton, R., Fox, J. D., Caswell, R., Sherratt, E., Wilkinson, G. W. G.
(2002). Analysis of the human herpesvirus-6 immediate-early 1 protein. J. Gen. Virol.
83: 2811-2820
[Abstract]
[Full Text]
-
Oster, B., Hollsberg, P.
(2002). Viral Gene Expression Patterns in Human Herpesvirus 6B-Infected T Cells. J. Virol.
76: 7578-7586
[Abstract]
[Full Text]
-
Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K., Yamanishi, K.
(2002). Identification of Human Herpesvirus 6 Latency-Associated Transcripts. J. Virol.
76: 4145-4151
[Abstract]
[Full Text]
-
Van den Bosch, G., Locatelli, G., Geerts, L., Faga, G., Ieven, M., Goossens, H., Bottiger, D., Oberg, B., Lusso, P., Berneman, Z. N.
(2001). Development of Reverse Transcriptase PCR Assays for Detection of Active Human Herpesvirus 6 Infection. J. Clin. Microbiol.
39: 2308-2310
[Abstract]
[Full Text]
-
Flebbe-Rehwaldt, L. M., Wood, C., Chandran, B.
(2000). Characterization of Transcripts Expressed from Human Herpesvirus 6A Strain GS Immediate-Early Region B U16-U17 Open Reading Frames. J. Virol.
74: 11040-11054
[Abstract]
[Full Text]
-
Mori, Y., Dhepakson, P., Shimamoto, T., Ueda, K., Gomi, Y., Tani, H., Matsuura, Y., Yamanishi, K.
(2000). Expression of Human Herpesvirus 6B rep within Infected Cells and Binding of Its Gene Product to the TATA-Binding Protein In Vitro and In Vivo. J. Virol.
74: 6096-6104
[Abstract]
[Full Text]
-
Norton, R. A., Caserta, M. T., Hall, C. B., Schnabel, K., Hocknell, P., Dewhurst, S.
(1999). Detection of Human Herpesvirus 6 by Reverse Transcription-PCR. J. Clin. Microbiol.
37: 3672-3675
[Abstract]
[Full Text]
-
Rotola, A., Cassai, E., Tola, M. R., Granieri, E., Di Luca, D.
(1999). Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry
67: 529-531
[Abstract]
[Full Text]
-
Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., Pellett, P. E.
(1999). Human Herpesvirus 6B Genome Sequence: Coding Content and Comparison with Human Herpesvirus 6A. J. Virol.
73: 8040-8052
[Abstract]
[Full Text]
-
Isegawa, Y., Mukai, T., Nakano, K., Kagawa, M., Chen, J., Mori, Y., Sunagawa, T., Kawanishi, K., Sashihara, J., Hata, A., Zou, P., Kosuge, H., Yamanishi, K.
(1999). Comparison of the Complete DNA Sequences of Human Herpesvirus 6 Variants A and B. J. Virol.
73: 8053-8063
[Abstract]
[Full Text]
-
Menegazzi, P., Galvan, M., Rotola, A., Ravaioli, T., Gonelli, A., Cassai, E., Di Luca, D.
(1999). Temporal mapping of transcripts in human herpesvirus-7. J. Gen. Virol.
80: 2705-2712
[Abstract]
[Full Text]
-
Menotti, L., Mirandola, P., Locati, M., Campadelli-Fiume, G.
(1999). Trafficking to the Plasma Membrane of the Seven-Transmembrane Protein Encoded by Human Herpesvirus 6 U51 Gene Involves a Cell-Specific Function Present in T Lymphocytes. J. Virol.
73: 325-333
[Abstract]
[Full Text]
-
Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., Di Luca, D.
(1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl. Acad. Sci. USA
95: 13911-13916
[Abstract]
[Full Text]